Safety, pharmacokinetics, efficacy, and preliminary biomarker data of first-in-class BI 765063, a selective SIRPa inhibitor: Results of monotherapy dose escalation in phase 1 study in patients with advanced solid tumors.
BI-765063
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Safety, pharmacokinetics, efficacy, and preliminary biomarker data of first-in-class BI 765063, a selective SIRPa inhibitor: Results of monotherapy dose escalation in phase 1 study in patients with advanced solid tumors. ### Output: BI-765063